HIV/AIDS Research
Study of RPI-MN completed indicating effectiveness in drug resistant HIV
Published in AIDS Weekly, October 17th, 2005
RPI-MN is the leading antiviral drug candidate of ReceptoPharm, Inc. and is being studied in preclinical assays for its efficacy in treating HIV/AIDS.
The ability of the HIV virus to establish resistance to therapeutic drugs through genetic mutation is a major concern in the treatment of HIV/AIDS. HIV does not always make perfect copies of itself. With billions of viruses being made every day, lots of small, random differences can occur. The differences are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-10-17)
More Articles from AIDS Weekly
- HIV/AIDS Diagnostics
Microchip CD4 counting method monitors HIV in resource-poor settings - HIV/AIDS Epidemiology
HIV-1 group M isolates are 100-fold-more fit than group 0 or HIV-2 strains - HIV/AIDS Pathogenesis
CD4+CD25+ regulatory T cells crucial in HIV infection - HIV/AIDS Transmission
Cervicovaginal lavage fluid contains an inhibitor of HIV binding to DC-SIGN - HIV/AIDS Treatment
HDAC inhibitor plus HAART accelerates HIV clearance from resting CD4+ cells - Adverse Drug Reaction
GSK makes changes to the development program for ONO-4128/873140 - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
